Berchuck A - Search Results

1

Progesterone receptor gene polymorphism and risk for breast and ovarian cancer.

Lancaster JM, Berchuck A, Carney ME, Wiseman R, Taylor JA. Lancaster JM, et al. Among authors: berchuck a. Br J Cancer. 1998 Jul;78(2):277. doi: 10.1038/bjc.1998.480. Br J Cancer. 1998. PMID: 9683307 Free PMC article. No abstract available.

2

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, Humphrey P, Berchuck A, Ponder BA, Bast RC Jr. Jacobs IJ, et al. Among authors: berchuck a. J Natl Cancer Inst. 1992 Dec 2;84(23):1793-8. doi: 10.1093/jnci/84.23.1793. J Natl Cancer Inst. 1992. PMID: 1433368

3

A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.

Jacobs IJ, Smith SA, Wiseman RW, Futreal PA, Harrington T, Osborne RJ, Leech V, Molyneux A, Berchuck A, Ponder BA, et al. Jacobs IJ, et al. Among authors: berchuck a. Cancer Res. 1993 Mar 15;53(6):1218-21. Cancer Res. 1993. PMID: 8095178

4

The p53 tumor suppressor gene frequently is altered in gynecologic cancers.

Berchuck A, Kohler MF, Marks JR, Wiseman R, Boyd J, Bast RC Jr. Berchuck A, et al. Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):246-52. doi: 10.1016/s0002-9378(94)70414-7. Am J Obstet Gynecol. 1994. PMID: 8296829 Review.

5

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.

Kohler MF, Marks JR, Wiseman RW, Jacobs IJ, Davidoff AM, Clarke-Pearson DL, Soper JT, Bast RC Jr, Berchuck A. Kohler MF, et al. Among authors: berchuck a. J Natl Cancer Inst. 1993 Sep 15;85(18):1513-9. doi: 10.1093/jnci/85.18.1513. J Natl Cancer Inst. 1993. PMID: 8360934

6

An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility gene.

Lancaster JM, Wiseman RW, Berchuck A. Lancaster JM, et al. Among authors: berchuck a. Obstet Gynecol. 1996 Feb;87(2):306-9. doi: 10.1016/0029-7844(95)00405-X. Obstet Gynecol. 1996. PMID: 8559544

7

Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation test.

Lancaster JM, Cochran CJ, Brownlee HA, Evans AC, Berchuck A, Futreal PA, Wiseman RW. Lancaster JM, et al. Among authors: berchuck a. J Natl Cancer Inst. 1996 Apr 17;88(8):552-4. doi: 10.1093/jnci/88.8.552. J Natl Cancer Inst. 1996. PMID: 8606385 No abstract available.

8

BRCA2 mutations in primary breast and ovarian cancers.

Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA. Lancaster JM, et al. Among authors: berchuck a. Nat Genet. 1996 Jun;13(2):238-40. doi: 10.1038/ng0696-238. Nat Genet. 1996. PMID: 8640235

9

BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.

Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Wiseman RW, Berchuck A, Iglehart JD, Futreal PA, Marks JR. Vaughn JP, et al. Among authors: berchuck a. Cell Growth Differ. 1996 Jun;7(6):711-5. Cell Growth Differ. 1996. PMID: 8780884

10

Role of BRCA1 mutation screening in the management of familial ovarian cancer.

Berchuck A, Cirisano F, Lancaster JM, Schildkraut JM, Wiseman RW, Futreal A, Marks JR. Berchuck A, et al. Am J Obstet Gynecol. 1996 Sep;175(3 Pt 1):738-46. doi: 10.1053/ob.1996.v175.a74288. Am J Obstet Gynecol. 1996. PMID: 8828444 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

640 results

Search Page

Filters